Global Regulatory Operations

Our proven processes and tools are designed to designed to deliver fast and high-quality submissions.

I appreciate your flexibility! I wish all CRO’s were as efficient as the MMS team.
Regulatory Operations Head
Leading Pharmaceutical Sponsor

Regulatory Operations experts at MMS are skilled at managing, preparing, and submitting a diverse array of regulatory submissions to global health authorities. Our team is committed to providing sponsors with personalized, automated, and forward-thinking end-to-end regulatory build and submission solutions by serving as an integrated extension of our Sponsor teams. Throughout the product life cycle, our validated document management systems, industry-leading eCTD publishing and validation systems, and on-the-ground support with certified teams allow for unparalleled accuracy and efficiency. MMS supports submissions in the US, Canada, AU, Swiss, EA/EU, UK, and GCC regions, among others.

Our preclinical to late-stage commercialization and global market expansion services include:

  • Pre-clinical support, including request for application numbers, filing intent to submit applications, meeting requests and briefing packages, and developing submission content plans.
  • Clinical development and global submissions of study authorization applications, including initial trial applications and amendments, scientific advice submissions, special designation submissions like fast-track designation, and special protocol assessment requests etc.
  • Submission management of marketing authorization applications, responses to requests for information, and post-approval life-cycle management and supplements, Advertisement Promotion, and SPL submissions.
Document Publishing

Our skilled team of experts prepares eCTD-ready documents using advanced automation, ensuring minimal effort and maximum quality. Our published documents comply with global regulatory requirements with enhanced submission navigation, aiding agency reviewers. Native files are processed to ensure submission readiness, including tasks such as bookmarking, linking, OCR, scaling, updating document properties, and optimizing. This process supports complex documents like RMPs, CRFs, and CSRs with enhanced and automated publishing capabilities.

We are proficient in a wide variety of document management and RIMS systems that Sponsors utilize, and we offer customized services tailored to meet their specific needs. For instance, we prepare native Word documents for automated rendering into submission-ready formats. Our robust QC processes ensure accurate PDF navigation and validation, and we have specialized checks for submission readiness, including anonymized documents and those intended for public disclosure.

End-to-end support: Submission Publishing and Agency Delivery

MMS experts provide end-to-end support from content plan preparation, document procurement, submission build, validation, and a 100% quality control check.  Our adaptable and proven processes, combined with our commitment to KPI-driven quality deliverables, ensure that our specialists generate submissions of the highest quality. Our project leads take on the critical task of coordinating the submission review with sponsor teams, seamlessly addressing client requirements to ensure a smooth submission process.

From document authoring to compilation, MMS proactively engages with sponsor teams to streamline activities, incorporate cross-departmental efficiencies, and simultaneously build multiple health authority applications, ensuring smooth regulatory submissions worldwide. Our global teams are always prepared to accommodate possible delays or risks that may set back the submission timeline. Our proven process and extensive experience ensure maximum reuse of published files and submission dossiers with minimum effort to clone and submit to diverse global regions. Your MMS  regulatory colleagues continuously monitor for risks and anticipate regulatory issues, proactively addressing them to ensure submissions are prepared and submitted according to, or ahead of, the sponsor’s or agency’s timeline.

eCTD Lifecycle Management

Maintain the most up-to-date documents and associated information for your application in one place, ensuring every health authority has what they need at all times. This includes ongoing maintenance of all future sequences, such as amendments, supplements, variations, Ad-Promos, SPLs, and more.

Submission Delivery

Our global teams are experienced with most major agency electronic portals, enabling us to dispatch submissions around the clock. This includes gateway portals such as the US FDA, Health Canada, EMA, MHRA, IRIS, and CTIS, among others.

Document Management

We understand platforms from simple document sharing systems to advanced RIMS solutions for document management and submission archival. Our specialists support multiple document management systems and provide custom support ensuing compliance to MMS and/or Sponsor’s archival processes.

Regulatory Information Management

The MMS team is well-trained and experienced and supports several regulatory information management (RIM) systems for our sponsors. Our RIM services include the creation of submission records along with the archival process, object creation and management (such as Events, Activities, Applications, Regulatory objectives, and Registrations), as well as data migration activities.

Sponsors are inclined to use systems that enable a centralized process to plan, manage, and track regulatory data, documents, and activities. Our teams leverage knowledge gained from working on different RIMS systems to provide dynamic support and comply with the Sponsors’ regulatory archival needs.

MMS regulatory specialists can help Sponsors identify gaps, set up structured and logical processes, develop SOPs and guidance materials, and train different vendor teams.

Suggested For You

webinar

September 26th, 2024

Regulatory Pathways for Nonprescription Drugs: A Deep Dive into OTC Monograph Reform and FDA Guidance

regulatory intelligence

August 27th, 2024

Recent Guidance on Diversity Action Planning

regulatory intelligence

August 26th, 2024

Oncology Programs at the FDA

regulatory intelligence

August 26th, 2024

Three Key Take Reflections on the Recent Donanemab Approval

webinar

September 12th, 2024

No Stone Unturned: Optimizing the Use of Expedited Pathways and Oncology Center of Excellence Programs to Optimize Drug Development in Oncology

regulatory intelligence

August 9th, 2024

FDA Updates 2024 Language Access Plan

regulatory intelligence

August 3rd, 2024

EMA Launches New Pilot Program for Orphan Medical Devices

perspectives

July 30th, 2024

The Critical Role of Quality Control (QC) – Medical Writing and Beyond

regulatory intelligence

July 26th, 2024

Key Decision Points for Recent Oncology Approvals

regulatory intelligence

July 24th, 2024

Comments Open for Postapproval Manufacturing Changes to Biosimilar and Interchangeable Biosimilar Products

perspectives

July 23rd, 2024

PSI 2024 Ignited Conversations on External Data Sources, Requirements for Estimands, and Bayesian Methodology for Statisticians in Pharma

news

July 17th, 2024

Industry Veteran Ben Dudley Joins MMS as Chief Commercial Officer (CCO) to Drive Continued Growth for the Data-focused Clinical Research Organization